Evidence map›Paper›PMID 36658347›Full record

ArticleJournal of human genetics2023

Analysis of LIN28A variants in patients with Parkinson's disease.

Hao Peng, Yuanzhe Li, Hiroyo Yoshino, Mai Shimizu, Kenya Nishioka, Manabu Funayama, Nobutaka Hattori

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Hao PengDepartment of Neurology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan.
Yuanzhe LiDepartment of Neurology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan.
Hiroyo YoshinoResearch Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan.
Mai ShimizuDepartment of Neurology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan.
Kenya NishiokaDepartment of Neurology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan.
Manabu FunayamaDepartment of Neurology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan.ORCID http://orcid.org/0000-0002-7412-3631
Nobutaka HattoriDepartment of Neurology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan. nhattori@juntendo.ac.jp.
Juntendo University · JPRIKEN Center for Brain Science · JP

Funding

Japan Agency for Medical Research and Development (AMED) 21ak0101125h0002MEXT | Japan Society for the Promotion of Science (JSPS) 18K07536MEXT | Japan Society for the Promotion of Science (JSPS) 19K08003MEXT | Japan Society for the Promotion of Science (JSPS) 20K07893MEXT | Japan Society for the Promotion of Science (JSPS) 21H04820MEXT | Japan Society for the Promotion of Science (JSPS) 21K07283Ministry of Education, Culture, Sports, Science and Technology (MEXT) High Technology Research Center Grant
6 · The paper itself

Abstract

A heterozygous loss-of-function variant in lin-28 homolog A (LIN28A) was recently reported as a novel pathogenic gene in patients with PD from Korea. Two patients harboring LIN28A variants had early- or middle-aged-onset PD with good responses to levodopa. In the current study, we aimed to identify the prevalence of LIN28A variants among PD patients of Japanese origin. We performed genetic sequencing of 284 patients with early-onset PD. We then estimated the frequency and functional effect of each variant using prediction tools. We identified three different rare variants in LIN28A (rs4623750, c.228 + 49 C > T; rs199541048, c.*7 A > G; and rs4659441, c.*43 C > T). The frequency of each variant in the PD patients did not differ from that of the general population. No variants were identified in the amino acid-coding regions. Our results do not support a strong association of LIN28A with early-onset PD among Japanese patients.

Indexed as

Parkinson DiseaseGenetic Predisposition to DiseaseHumansLevodopaLoss of HeterozygosityMiddle AgedRNA-Binding ProteinsLevodopaLin28A protein, humanRNA-Binding Proteins

Identifiers

PMID36658347
OpenAlexW4317567527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.